External validation of the risk assessment model of the international medical prevention registry on venous thromboembolism (IMPROVE) for medical patients in a tertiary health system

Journal of the American Heart Association

Volumn 3, Issue 6, 2014, Pages

  Rosenberg, David ^a   Eichorn, Ann ^b   Alarcon, Mauricio ^a   McCullagh, Lauren ^a   McGinn, Thomas ^a   Spyropoulos, Alex C ^a  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b Northwell Health   (United States)

Author keywords

Clinical prediction rules; Hospitalized medical patients; Risk assessment models; Thromboprophylaxis; Venous thromboembolism

Indexed keywords

AGED; AREA UNDER THE CURVE; ARTICLE; CHOLECYSTITIS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY CARE UNIT; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE REGISTRY; EXTERNAL VALIDITY; FEMALE; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; IMMOBILITY; INCIDENCE; INFECTION; INFLAMMATORY BOWEL DISEASE; INFORMED CONSENT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PANCREATITIS; PARALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT INFECTION; RHEUMATIC DISEASE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; TERTIARY HEALTH CARE; THROMBOPHILIA; UNITED STATES; VENOUS THROMBOEMBOLISM; BLEEDING; CHEMICALLY INDUCED; CLINICAL TRIAL; DECISION SUPPORT SYSTEM; MIDDLE AGED; MULTICENTER STUDY; REPRODUCIBILITY; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; TIME FACTOR; TREATMENT OUTCOME; VALIDATION STUDY; VENOUS THROMBOSIS; VERY ELDERLY;

FIBRINOLYTIC AGENT;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; DECISION SUPPORT TECHNIQUES; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOSIS;

EID: 84936787634     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.001152     Document Type: Article

References (22)

1. Anderson FA, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol. 2007;82:777-782.
2. Belch JJ, Lowe GD, Ward AG, Forbes CD, Prentice CR. Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J. 1981;26: 115-117.
3. Nielsen HK, Bechgaard P, Nielsen PF, Geday E, Husted SE. [Fatal pulmonary embolism in a medical department. Clinic-pathological correlations and therapeutic deliberations]. Ugeskr Laeger. 1981;143:1956-1960.
4. Flanders SA, Greene MT, Grant P, Kaatz S, Paje D, Lee B, Barron J, Chopra V, Share D, Bernstein SJ. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism: a cohort study. JAMA Intern Med. 2014;174:1577-1584.
5. Qaseem A, Chou R, Humphrey LL, Starkey M, Shekelle P; Physicians CGCotACo. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;155:625-632.
6. Quality AfHRa. Chapter 2. Lay out the evidence and identify best practices: preventing hospital-acquired venous thromboembolism. August 2008; 2014.
7. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH; Physicians ACoC. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e195S-e226S.
8. Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost. 2005;94:750-759.
9. Kucher N, Tapson VF, Goldhaber SZ; Committee DFS. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost. 2005;93:494-498.
10. Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH, Zotz RB, Bergmann JF, Tapson V, Froehlich JB, Monreal M, Merli GJ, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA; Investigators I. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011;140:706-714.
11. Woller SC, Stevens SM, Jones JP, Lloyd JF, Evans RS, Aston VT, Elliott CG. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am J Med. 2011;124:947-954.e942.
12. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8:2450-2457.
13. Maynard GA, Morris TA, Jenkins IH, Stone S, Lee J, Renvall M, Fink E, Schoenhaus R. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE Risk Assessment Model. J Hosp Med. 2010;5:10-18.
14. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA. 2000;284:79-84.
15. Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, Spyropoulos AC, Merli GJ, Zotz RB, Bergmann JF, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA, Fitzgerald G, Anderson FA; Investigators I. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132:936-945.
16. Nendaz M, Spirk D, Kucher N, Aujesky D, Hayoz D, Beer JH, Husmann M, Frauchiger B, Korte W, Wuillemin WA, Jäger K, Righini M, Bounameaux H. Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit assessment of thromboembolic risk and prophylaxis for medical patients in Switzerland (ESTIMATE). Thromb Haemost. 2014;111:531-538.
17. Spyropoulos AC. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Chest. 2005;128:958-969.
18. Cohen AT, Spiro TE, Spyropoulos AC, Desanctis YH, Homering M, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Tapson VF, Burton P; Group MS. D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial. J Thromb Haemost. 2014;12:479-487.
19. Mahan CE, Liu Y, Turpie AG, Vu JT, Heddle N, Cook RJ, Dairkee U, Spyropoulos AC. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR). Thromb Haemost. 2014;112:692-699.
20. Huang W, Anderson FA, Spencer FA, Gallus A, Goldberg RJ. Risk-assessment models for predicting venous thromboembolism among hospitalized nonsurgical patients: a systematic review. J Thromb Thrombolysis. 2013;35:67-80.
21. Cook LM, Kahn SR, Goodwin J, Kovacs MJ. Frequency of renal impairment, advanced age, obesity and cancer in venous thromboembolism patients in clinical practice. J Thromb Haemost. 2007;5:937-941.
22. Kakkar AK, Cimminiello C, Goldhaber SZ, Parakh R, Wang C, Bergmann JF; Investigators L. Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med. 2011;365:2463-2472.